Literature DB >> 18670004

Ethnicity and quality of antipsychotic prescribing among in-patients in south London.

Anne Connolly1, David Taylor.   

Abstract

Ethnicity may influence treatment decisions in mental disorders. We undertook a survey of the prescribing of antipsychotics for in-patients in three south London mental health trusts. A total of 255 patients (152 White, 103 Black) were included. Median dose of antipsychotic (% of licensed dose) was 58.3% for White and 50.0% for Black patients (adjusted effect size=0.14, 95% CI -0.34 to 0.63). High-dose antipsychotics were prescribed to 15.1% of White and 11.7% of Black patients (adjusted odds ratio (OR)=0.5, 95% CI 0.19-1.33), and antipsychotic polypharmacy was recorded for 25.7% and 31.1% respectively (adjusted OR=3.05, 95% CI 1.44-6.46). Prescribing quality was similar for Black and White patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670004     DOI: 10.1192/bjp.bp.108.050427

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

Review 1.  Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

Authors:  Juan A Gallego; John Bonetti; Jianping Zhang; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2012-04-24       Impact factor: 4.939

2.  Does race affect prescribing for acute psychosis? Evaluation by a case vignette.

Authors:  Anne Connolly; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

3.  Factors associated with non evidence-based prescribing of antipsychotics.

Authors:  Anne Connolly; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

4.  Increased use of antipsychotic long-acting injections with community treatment orders.

Authors:  Maxine X Patel; Jane Matonhodze; Mirza K Baig; James Gilleen; Jane Boydell; Frank Holloway; David Taylor; George Szmukler; Tim Lambert; Anthony S David
Journal:  Ther Adv Psychopharmacol       Date:  2011-04

5.  The effect of ethnicity on prescribing practice and treatment outcome in inpatients suffering from schizophrenia in Greece.

Authors:  Athanassios Douzenis; Athanassios Apostolopoulos; Dionisios Seretis; Emmanouil N Rizos; Christos Christodoulou; Lefteris Lykouras
Journal:  BMC Psychiatry       Date:  2011-04-20       Impact factor: 3.630

6.  Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.

Authors:  Christopher J Miller; Mingfei Li; Robert B Penfold; Austin F Lee; Eric G Smith; David N Osser; Laura Bajor; Mark S Bauer
Journal:  BMC Psychiatry       Date:  2014-11-30       Impact factor: 3.630

7.  Antipsychotic prescribing of consultant forensic psychiatrists working in different levels of secure care with patients with schizophrenia.

Authors:  Anna Machin; Lucy McCarthy
Journal:  BJPsych Bull       Date:  2017-04

8.  Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: findings from a nationally representative cross-sectional study.

Authors:  Jayati Das-Munshi; Dinesh Bhugra; Mike J Crawford
Journal:  BMC Med       Date:  2018-04-18       Impact factor: 8.775

9.  Second-generation antipsychotics and metabolic side-effects: Canadian population-based study.

Authors:  Lauren Hirsch; Scott B Patten; Lauren Bresee; Nathalie Jette; Tamara Pringsheim
Journal:  BJPsych Open       Date:  2018-07

10.  A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting.

Authors:  Thomas Maestri; David Anderson; Jose Calderon-Abbo; Taylor Waguespack; Margarita Echeverri
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.